Phase I/II Study of Ribavirin Given as Monotherapy in Solid Tumour Cancer Patients
Use of Ribavirin and Low Dose Ara-C to Treat Acute Myeloid Leukemia
Treatment With Ribavirin for Patients With Metastatic Breast Cancer
A Study of Ribavirin to Treat M4 and M5 Acute Myelocytic Leukemia
† Study has passed its completion date and status has not been verified in more than two years.